ASHLEY HILL: Open Payments
NPI 1477819936 · LEWES, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,159 in 60 payments from 15 companies in 2025. Trend: 2023 $1,132 · 2024 $932 · 2025 $1,159
Food & beverage: $1,159
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 14 | $243 |
| Novartis Pharmaceuticals Corporation | 12 | $214 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 8 | $180 |
| SCPHARMACEUTICALS INC. | 5 | $102 |
| AstraZeneca Pharmaceuticals LP | 4 | $91 |
| Amgen Inc. | 5 | $79 |
| Merck Sharp & Dohme LLC | 3 | $64 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $43 |
| Baxter Healthcare | 1 | $31 |
| Vital Connect, Inc | 1 | $26 |
Products named: LEQVIO, LifeVest, ELIQUIS, VYNDAQEL, FUROSCIX, REPATHA, VERQUVO, FARXIGA.
Industry payments across DE — which companies pay providers there.
